Application of human herpesvirus (HHV) -6 and HHV-7 to the gene therapy vectors
Kondo, K.
Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 3): 518-522
2006
ISSN/ISBN: 0047-1852 PMID: 16615527 Document Number: 595601
Document emailed within 1 workday
Related Documents
Sandoval Rodríguez, A.S.; Salazar Montes, A.M.ía.; Armendáriz-Borunda, J. 2005: Viral vectors in gene therapy. Advantages of the adenoassociated vectors Revista de Gastroenterologia de Mexico 70(2): 192-202Schneider, H. 1997: Vectors for gene therapy Medizinische Monatsschrift für Pharmazeuten 20(4): 98-102
Chao, H.; Walsh, C.E. 2004: AAV vectors for hemophilia B gene therapy Mount Sinai Journal of Medicine new York 71(5): 305-313
Romero, E.L.; Morilla, M.J.; Bakas, L.S. 2001: Lipid vectors. new strategies for gene therapy Medicina 61(2): 205-214
Wilson, J.M. 1997: Vectors--shuttle vehicles for gene therapy Clinical and Experimental Immunology 107(Suppl 1): 31-32
Strayer, D.S.; Zern, M.A.; Chowdhury, J.R. 2002: What can SV40-derived vectors do for gene therapy? Current Opinion in Molecular Therapeutics 4(4): 313-323
Silman, N.J.; Fooks, A.R. 2000: Biophysical targeting of adenovirus vectors for gene therapy Current Opinion in Molecular Therapeutics 2(5): 524-531
Latchman, D.S. 1999: Gene therapy with herpes simplex virus vectors Archivum Immunologiae et Therapiae Experimentalis 47(6): 335-340
Connelly, S. 1999: Adenoviral vectors for liver-directed gene therapy Current Opinion in Molecular Therapeutics 1(5): 565-572
Ichikawa, T.; Saeki, Y.; Tamiya, T.; Chiocca, E.A.; Ohmoto, T. 2000: Herpes simplex type-1 virus-based vectors for gene therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 58(4): 822-827
Parker, A.L.; Nicklin, S.A.; Baker, A.H. 2008: Interactions of adenovirus vectors with blood: implications for intravascular gene therapy applications Current Opinion in Molecular Therapeutics 10(5): 439-448
Little, P.F.; Treisman, R.; Bierut, L.; Seed, B.; Maniatis, T. 1983: Plasmid vectors for the rapid isolation and transcriptional analysis of human beta-globin gene alleles Molecular Biology and Medicine 1(5): 473-488
Małecki, M.; Swoboda, P.ł; Pachecka, J. 2009: Recombinant adeno-associated virus derived vectors (rAAV2) efficiently transduce ovarian and hepatocellular carcinoma cells--implications for cancer gene therapy Acta Poloniae Pharmaceutica 66(1): 93-99
Yang, S.; Li, J-li.; Bi, H-chang.; Zhou, S-ning.; Liu, X-man.; Zeng, H.; Hu, B-fang.; Huang, M. 2016: Construction and function identification of luciferase reporter gene vectors containing SNPs in NFKBIA gene 3'UTR Yao Xue Xue Bao 51(1): 80-85
Fei, L.-N.; Wang, Q.-Z.; Xu, R.-A. 2012: Combinatorial RNAi and its application in cancer gene therapy Yao Xue Xue Bao 47(5): 573-579
Tang, D.C.; Carbone, D.P. 1993: Potential application of gene therapy to lung cancer Seminars in Oncology 20(4): 368-373
Seth, P.; Brinkmann, U.; Schwartz, G.N.; Katayose, D.; Gress, R.; Pastan Ira; Cowan, K. 1996: Adenovirus-mediated gene transfer to human breast tumor cells: an approach for cancer gene therapy and bone marrow purging Cancer Research 56(6): 1346-1351
Hlavatý, J.; Hlubinová, K.; Bies, J.; Altaner, C. 1999: Cells producing recombinant retrovirus with thymidine kinase gene from Herpes simplex virus suitable for human cancer gene therapy Neoplasma 46(6): 329-334
Chen, Y.; Lü, Y.-H.; Li, Z.-F. 2014: Advances in the application of gene therapy for Parkinson's disease with adeno-associated virus Yao Xue Xue Bao 49(5): 576-581
Jin, M.-J.; Liu, B.; Zhang, S.-S.; Zhang, Y.-J.; Xu, M.; Ma, X.-Y.; Yao, K.-Y.; Chen, K. 2008: Application of multifactor dimensionality reduction on the interactions between gene-gene, gene-environment and the risk sporadic colorectal cancer in Chinese population Zhonghua Liu Xing Bing Xue Za Zhi 29(6): 535-539